ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
United Health Products Inc (PK)

United Health Products Inc (PK) (UEEC)

0.081
-0.0121
(-13.00%)
마감 15 11월 6:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
0.081
매수가
0.0809
매도가
0.15
거래량
414,963
0.0809 일간 변동폭 0.0929
0.072 52주 범위 0.2825
market_cap
전일 종가
0.0931
개장가
0.086
최근 거래 시간
110000
@
0.081
마지막 거래 시간
재정 규모
US$ 34,255
VWAP
0.08255
평균 볼륨(3m)
173,990
발행 주식
248,433,222
배당수익률
-
주가수익률
-7.55
주당순이익(EPS)
-0.01
매출
-
순이익
-2.62M

United Health Products Inc (PK) 정보

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the dental, healthcare, veterinary and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, designed to absorb exudate/drainage from su... United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the dental, healthcare, veterinary and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, designed to absorb exudate/drainage from superficial wounds and helps control bleeding. 더 보기

섹터
Ortho,prosth,surg Appl,suply
산업
Ortho,prosth,surg Appl,suply
웹사이트
본부
Henderson, Nevada, USA
설립됨
-
United Health Products Inc (PK) is listed in the Ortho,prosth,surg Appl,suply sector of the OTC 시장 with ticker UEEC. The last closing price for United Health Products (PK) was US$0.09. Over the last year, United Health Products (PK) shares have traded in a share price range of US$ 0.072 to US$ 0.2825.

United Health Products (PK) currently has 248,433,222 shares in issue. The market capitalisation of United Health Products (PK) is US$23.13 million. United Health Products (PK) has a price to earnings ratio (PE ratio) of -7.55.

UEEC 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.02-19.8019801980.1010.10490.08092253130.09874788CS
4-0.0189-18.91891891890.09990.1450.08091488960.10689902CS
12-0.0825-50.45871559630.16350.190.0721739900.12364055CS
26-0.0902-52.68691588790.17120.20990.0721310000.14085743CS
52-0.184-69.43396226420.2650.28250.0721462480.18166688CS
156-0.789-90.68965517240.870.942550.0721406290.29734453CS
260-1.079-93.01724137931.161.910.0721220100.53908296CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
HLLPFHello Pal International Inc (CE)
US$ 0.001
(99,900.00%)
1,000
OVITOncoVista Innovative Therapies Inc (CE)
US$ 0.0002
(19,900.00%)
3.74k
MMEXMMEX Resources Corporation (PK)
US$ 0.0001
(9,900.00%)
6.54M
QGRSFQ2 Gold Resources Inc (CE)
US$ 0.001
(9,900.00%)
1,000
HYGNHydrogenetics Inc (CE)
US$ 0.0001
(9,900.00%)
5k
VIVEViveve Medical Inc (CE)
US$ 0.000001
(-99.89%)
505
DMSLQDigital Media Solutions Inc (CE)
US$ 0.0001
(-99.80%)
322
BTAEFBeta Energy Corporation (CE)
US$ 0.000001
(-99.80%)
885
FUNFFFansUnite Entertainment Inc (CE)
US$ 0.000001
(-99.75%)
61.83k
PACVPacific Ventures Group Inc (CE)
US$ 0.000001
(-99.50%)
28k
RDARRaadr Inc (PK)
US$ 0.0007
(-12.50%)
320.18M
TONRTonner One World Holdings Inc (PK)
US$ 0.0003
(0.00%)
291.23M
THBDThird Bench Inc (PK)
US$ 0.00025
(25.00%)
182.02M
HMBLHUMBL Inc (PK)
US$ 0.0003
(0.00%)
110.4M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(-50.00%)
105.11M

UEEC Discussion

게시물 보기
JimmyRich JimmyRich 3 시간 전
414k shares traded today.. and yes absolutely more sellers than buyers… 414k is a lot of shares for us to trade market makers tracking as many cheap shares as they can.. if someone is foolish enough to sell at these levels the MM’s will take it as cheap as possible
👍️0
rodman rodman 13 시간 전
RFK to be the new Director of H&H Resources. Maybe he changes the disinformation FDA seems to rely upon and
produce in their PMA reviews. APPROVE the CelluSTAT (fka HemoStyp)!
$5-$10+
👍️0
Hoonigan Hoonigan 1 일 전
Yep there are more sellers than buyers. I think this will stay this way for a while until the Bioresearch Monitoring Program feed back is a thumbs up and the trials results are positive. Which in my opinion is a benefit and was an overlooked step before previous trials with moving manufacturing from China to a nice FDA approved facility. They will need more cash and if it was me I would partner with a company to get them to the finish line that is interested in a buying them out vs the White Lion Boys. Having a big name sponsor would also shoot this stock up a bunch and help them out too.
👍️ 1
JimmyRich JimmyRich 2 일 전
Absolutely Rodman someone will buy us out.. someone with the money and the connections in the industry will bring this all the way home there’s no question there..
👍️0
rodman rodman 2 일 전
10Q also stated..."In anticipation of receiving a Class III PMA (which cannot be assured), we are evaluating paths to rapidly grow our revenue and profits in all potential market segments, with the objective of maximizing shareholder value. We do not intend to pursue the full commercialization of our products independently nor to remain an independent company in the long term. Options under consideration include (i) a sale or merger of the Company with an industry leader in the wound care and surgical device sectors, which may include a pre-sale collaboration on commercialization and distribution and (ii) one or more commercial partnerships with established market participants, without any specific, associated sale or merger transaction."
$5-$10+
👍️0
JimmyRich JimmyRich 2 일 전
Thank you both for the info.. probably you guys are the most in the know without being cynical or making your personal interests influence your statements.. I really wish I could understand why this is happening to us.. when we really should see ourselves going in the right direction.. this pps is an absolute joke I mean whoever is able to buy it now is really in a great position.: the problem is they don’t know UEEC exists
👍️0
JimmyRich JimmyRich 2 일 전
Thank you both for the info.. probably you guys are the most in the know without being cynical or making your personal interests influence your statements.. I really wish I could understand why this is happening to us.. when we really should see ourselves going in the right direction.. this pps is an absolute joke I mean whoever is able to buy it now is really in a great position.: the problem is they don’t know UEEC exists
👍️0
Hoonigan Hoonigan 2 일 전
The form 10-Q provided some more details on their status with the FDA, which was nice see.
Some Stats
Shares outstanding 250,083,222
Shares traded last 3 months 4,357,108, 1.74% of shares outstanding, $0.107 average price, estimated $467,783 traded
Shares traded last 6 months 16,811762, 6.72% of shares outstanding, $0.151 average price $2,550,644 traded
Shares sold to White Lion (1/24-9/24) 4,850,000, $811,641
everybody is getting some great pricing -- Surfs up
The World Surf League Big Wave Contest (invitation only) is kicking off. This event is insane - they get a few days notice on when the event will take place.
👍️0
trusttheman trusttheman 2 일 전
I'm working on something with this stock. Reason the FDA is pulling this crap is because nobody knows about the product. I guarantee 99% of the doctors have no clue what it is. They only use what they are told to use. You have to change that. Once the public knows, the shorts are screwed and the FDA will feel the heat.
👍️ 1 👎️ 1 🤣 1
RetDrug RetDrug 7 일 전
If I put anymore in will it stop the sinking?
👍️0
RetDrug RetDrug 1 주 전
Yes I still own it.
Why I don’t know
Should of bailed years ago
It’s like the never ending story!
👍️0
shoondale shoondale 1 주 전
The FDA isn't preventing sales outside the USA...something must be terribly wrong with this bandage for desperate third world nations to pass it up.
👍️0
Chrism0000 Chrism0000 1 주 전
It's about getting favors from the FDA who is run by the government money talks bull sh walks
👍️0
TJAJ TJAJ 1 주 전
Please explain why the Democrats would sabotage UEEC?
👍️ 1
Chrism0000 Chrism0000 1 주 전
I just found out that Johnson & Johnson are the Democrats fourth biggest donor that's why I think UEEC  is getting screwed over 
👍️0
schiffy schiffy 1 주 전
What is the other board
👍️0
JimmyRich JimmyRich 1 주 전
RFK jr says the FDA needs to go
👍️0
rodman rodman 1 주 전
No one can presume anything when dealing with the FDA? The other board is telling since there were 3350 views today alone!
Looks like there is a growing interest in UEEC whether your a flipper or a dipper? LOAD UP YOUR BOAT!!!
$5-$10++
👍️0
schiffy schiffy 1 주 전
Did anyone think such an important medical device would be approved on one clinical study?
👍️0
trusttheman trusttheman 1 주 전
What’s keeping it down is the no balls people running this company as well as the incompetent stupidity of the FDA. The morons at the FDA keep taking advantage of the company with their stupid games because they know they are afraid.
👍️0
JimmyRich JimmyRich 1 주 전
Amazing how the market makers are holding this down.. they put up a wall at .108
👍️0
Chrism0000 Chrism0000 1 주 전
TRUMP!! TRUMP!! TRUMP!!
👍️0
Hoonigan Hoonigan 1 주 전
It is interesting that the day traders here are armatures. They don't realize that you make money by driving the price down then up to make money on good news. I own ATHA and the day trader guys there are crazy good and masterful! There is 39 million shares outstanding and 239 million shares were traded in one day 4 days ago and they are still working it up 54%. That is over 6 times the shares available to trade! My truck is still has some more room thanks to the armature day traders. Ernie gave it his best shot, they're like George caught on the treadmill.
👍️0
JimmyRich JimmyRich 1 주 전
Hey Hoonigan!!!! I like you.. actually made sense.. and wherever he is because you..: well you do know they’re the same person??? One appears the other appears.. One disappears the other disappears pretty ironic… Don’t worry about that you seem to have a good understanding of what’s going on. Keep the faith we will get where we need to be soon enough.
👎️ 1 🤣 1
Hoonigan Hoonigan 1 주 전
Where's Borax and Shonney going?
👍️0
Hoonigan Hoonigan 1 주 전
Time to load up another truck at these prices since they will not stay this low much longer. They only need to find 3-5 sites for the surgical procedures. This is a slam dunk and they have already did it at a much higher scale.
👍️ 1 👎️ 1 🙂 1 🤣 1
Chrism0000 Chrism0000 1 주 전
F!!! !!! THESE LOW LIFE COMMIE PIECES OF S***
👍️0
JimmyRich JimmyRich 2 주 전
No question this is all great news… it almost seems like the FDA wants to get us there.. it’s a few more hurdles but we will get over them
👍️0
JimmyRich JimmyRich 2 주 전
No question this is all great news… it almost seems like the FDA wants to get us there.. it’s a few more hurdles but we will get over them
👍️0
rodman rodman 2 주 전
Increasing the valuation also makes a buyout/merger possible moving forward IMO! The product is proven and engaging
with another entity with financial resources could accelerate the clinical testing in the surgical setting. "UHP has proposed to enroll a limited number of human subjects in a multi-site study as an extension of the original pivotal study, with patients undergoing surgical procedures within the organ space. Separately, the FDA confirmed that its earlier stated concern regarding use of CelluSTAT in vascular graft procedures had been adequately addressed."
Studys require resources!
$5-$10++
👍️ 1
Hoonigan Hoonigan 2 주 전
Amen, Jimmy! -- the additional study will Increase the Valuation and provide some drafting to quickly pass through he FDA approval hurdle. It is especially cool when you tie the testing with having completed two FDA Bioresearch Monitoring manufacturing site visits. They have the ability to now use the recently manufacturing product with an approved process for the additional trial testing. This will close the loop on any doubt of getting this over the FDA finish line. Shake and Bake time.
👍️ 1 👎️ 1 🤣 1
JimmyRich JimmyRich 2 주 전
I hear you Trust I’m with you but don’t lose focus now we’re in the home stretch.. The FDA obviously likes our product because they’re working with us and paused us which is a major plus they could have started the clock over.. also this is what happens with small companies like us, it takes years and dedication to get this done.. I’m here for years and no I’m not in at sub .10 like others I’m in way higher.. I wish my pps was some people’s.. That being said another 9 months will not make a huge difference (God willing) we’ll all be here celebrating approval.. can’t let go of the wheel now we’re starting to see the light at the end of the tunnel.. GL
👍️0
trusttheman trusttheman 2 주 전
I said 5 years ago the FDA was totally corrupt and influenced by J&J. They were given very specific parameters during the original trials which they followed to the letter. Now the corrupt FDA has decided to make up new clinical trial parameters with no justification whatsoever. The reason they are doing it is because they know the company is afraid of them and won't get into legally. In 7 months, they will come up with some other B.S. as they will try to bankrupt the company and leave a pile of crap product out there in Surgicrap which essentially is costing people their lives. I give you our government.
👍️ 2 🤣 1
dogooder dogooder 2 주 전
Morning all, well, I was right that we would hear something soon, I must say that while there is some positive news, we are going to have to wait a long time to resolve these trails, so I am disappointed, no hiding the truth
👍 1
rodman rodman 2 주 전
No doubt IMO that FDA is a believer in the efficacy of the hemostyp product!
https://finance.yahoo.com/news/united-health-products-provides-fda-130000023.html

"Notwithstanding the statistical conclusions of the clinical trial results, the FDA would like to see more data to confirm the safety and effectiveness of CelluSTAT in surgical procedures in the intestinal and thoracic organ space, where organ movement can impact the postoperative stability of a hemostat and where observation of postoperative rebleeding is more difficult. To address this concern, UHP has proposed to enroll a limited number of human subjects in a multi-site study as an extension of the original pivotal study, with patients undergoing surgical procedures within the organ space. Separately, the FDA confirmed that its earlier stated concern regarding use of CelluSTAT in vascular graft procedures had been adequately addressed."

“While we are pleased to confirm the path to resolving the list of deficiencies in our PMA application, we are disappointed that the strong results of our pivotal study and low incidence of adverse events were not sufficient to address the FDA’s specific concern regarding organ space applications of our device. The company will devote its resources to completing these additional surgical procedures efficiently and is confident that the results will reinforce the results of the existing study.”
I am buying more shares!!
$5-$10++
👍️0
rodman rodman 2 주 전
Yep no worries!
$5-$10+
👍️0
JimmyRich JimmyRich 2 주 전
Nice post… agreed
👍️0
dogooder dogooder 2 주 전
For the good guys on this board, you know who you are, the others, who cares.
I don't know when the outcome of the fda meeting with the company will be announced, maybe it will, maybe it won't, but upon conclusion, the direction of this company will be determined, praying and hoping the direction is forward, we will find out soon enough, cannot stay silent forever. I think it happens very soon
👍️0
dogooder dogooder 2 주 전
For the good guys on this board, you know who you are, the others, who cares.
I don't know when the outcome of the fda meeting with the company will be announced, maybe it will, maybe it won't, but upon conclusion, the direction of this company will be determined, praying and hoping the direction is forward, we will find out soon enough, cannot stay silent forever. I think it happens very soon
👍️ 2
JimmyRich JimmyRich 2 주 전
That pps keeps going where the market makers put us… the trading desks are controlling us… it will be nice when we get some real nice news and the volume comes in and the MM’s won’t be able to do that.. Hang in there Rod we’re making progress
👍️0
rodman rodman 2 주 전
No news could indicate UEEC is awaiting an FDA determination or at least still reviewing the 8/16 reply to the FDA’s June 18 “Deficiencies Letter” Lets enjoy the continuing increase in pps!
$5-$10+

https://uhpcorp.com/united-health-products-submits-response-letter-to-fda/
👎️ 1 🤣 1
RetDrug RetDrug 2 주 전
We shall see
👍️0
Chrism0000 Chrism0000 3 주 전
SOON!!! as TRUMP!!!!!!!!!!!!! wins all stocks will FLY!!!!!!!!!!!!!!!!!!!!!!!!!!!!
👍️0
Chrism0000 Chrism0000 3 주 전
SOON!!! as TRUMP!!!!!!!!!!!!! wins all stocks will FLY!!!!!!!!!!!!!!!!!!!!!!!!!!!!
👍️ 1
shoondale shoondale 3 주 전
The PMA and FDA news, since 2017, has been coming. How has that worked out? It hasn't amounted to more than a hill of bullshit. Pump and dump on suckers.
https://www.otcmarkets.com/filing/conv_pdf?id=12414685&guid=FSL-knG_sr4-dth
"We have has seen a .05 increase from 10/14 of .09 to the current .145. Do your due diligence but clearly the market is optimistic that the pps is the result of oversold and nefarious manipulation by hedge fund traders and their brokers selling to each other driving the pps down.The PMA submission and FDA news coming within 30 days."
Isn't your last $5+ play, QTMM, a delisted and bankrupted POS where shareholders lost every last penny to the scammers manipulating them?
"$5-$10+"
"FDA Selects HemoStyp ® for CtQ Pilot ProgramHenderson, Nevada – December 4, 2017 –United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp®, a patented hemostaticgauze for the healthcare and wound care sectors, today announced that it is proceeding with its application for HemoStyp under the FDA’s new and innovative CtQPilot Program. The FDA selected UHP’s HemoStyp as only one of nine participants for the program. UHP management has scheduled its first face-to-face meetingwith FDA experts for January 17, 2018 to provide the agency with whatever information it needs to advance the application for premarket approval (PMA).The FDA has stated that it intends to work collaboratively with pilot program participants during the review of their PMA submission to define characteristics ofthe device that are critical to product quality, and how these characteristics are controlled in design and manufacturing prior to the postmarket inspection. For pilotprogram participants, the FDA would forego conducting the standard PMA preapproval inspection, and a postmarket inspection focusing on the PMA applicant’simplementation of the critical to quality characteristics would be conducted instead.
The CtQ Pilot Program was created to identify products that have a chemical makeup of demonstrated safe interaction with the body –as evidenced by years ofprior product usage and studies-- to be approved for Class III internal surgical use. The program’s intent is to allow products that have demonstrated repeated safeinteraction to enter the market in a more efficient manner. This application will run simultaneously with the company’s prior Class II application for expandedindication. The market for 2017 internal surgical market for hemostatic products is estimated at in excess of seven billion dollars, and is expected to grow at 7.1%over the next few years, to reach more than $8.3 billion by 2022. (http://industryarc.com/Report/15189/hemostats-market.html)
Concurrent with its CtQ Pilot Program participation, UHP reaffirms that its current Class II application – Expanded Indication submission with the US FDA--continues to progress, and is in an advanced stage of review"
👍️ 1
shoondale shoondale 3 주 전
Thom got out while the getting was good. Who better to know an overpriced POS?:
SEC Transactions Last 2 Years
Trans Date Filer Ownership Type Price Shares
05/12/2023 THOM BRIAN DAVID
Officer Direct Sell 0.19 300,000
04/17/2023 THOM BRIAN DAVID
Officer Direct Acquisition (Non Open Market) 0.22 309,375
01/13/2023 THOM BRIAN DAVID
Officer Direct Acquisition (Non Open Market) 0.27 225,000
https://www.otcmarkets.com/stock/UEEC/disclosure
👍️0
rodman rodman 3 주 전
We have has seen a .05 increase from 10/14 of .09 to the current .145. Do your due diligence but
clearly the market is optimistic that the pps is the result of oversold and nefarious manipulation by
hedge fund traders and their brokers selling to each other driving the pps down.
The PMA submission and FDA news coming within 30 days.
$5-$10+
👍️ 2
JimmyRich JimmyRich 3 주 전
Hoon we’re getting there… I don’t care what these 2 say we legit have a company working to cross the finish line.. we have a CEO that gets compensated in stock.. why so he can sell at .10???? Come on these guys have incentive to get this done you and I both know it or are at least understanding that we’re still in the game… We’re heavily shorted which is wonderful because I can’t wait until shorts need to cover that’s a wonderful thing.. Nay sayers will post nonsense let’s keep the faith… I have a position that’s life altering… I hope you and a few others that deserve it also have sizable positions
👍 1 👎️ 1 🤣 1
JimmyRich JimmyRich 3 주 전
Hoon we’re getting there… I don’t care what these 2 say we legit have a company working to cross the finish line.. we have a CEO that gets compensated in stock.. why so he can sell at .10???? Come on these guys have incentive to get this done you and I both know it or are at least understanding that we’re still in the game… We’re heavily shorted which is wonderful because I can’t wait until shorts need to cover that’s a wonderful thing.. Nay sayers will post nonsense let’s keep the faith… I have a position that’s life altering
👍️ 1
Hoonigan Hoonigan 3 주 전
Some times crossing the finish line is not always pretty but it is all about the finish, which is on its way.
👎️ 1 🤣 1

최근 히스토리

Delayed Upgrade Clock